1Maloney D G, Smith B, Rose A. Rituximab: mechanism of action and resistance [J]. Semin Oncol, 2002,29(1 Suppl 2):2-9. 被引量：1
2Wilson W H, Gutierrez M, O'Connor P, et al. The role of rituximab and chemotherapy in aggressive B-cell lymphoma: a preliminary report of dose- adjusted EPOCH - R[J].Semin Oncol, 2002,29(1 Suppl 2):41-47. 被引量：1
3Czuczman M S, Fallon A, Mohr A, et al.Rituximab in combination with CHOP or fludarabine in low-grade lymphoma [J].Semin Oncol, 2002,29(I Suppl 2):36-40. 被引量：1
4NAPARSTEK E. The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma[J]. Curr Hematol Rep, 2005,4 (4) : 276-283. 被引量：1
5CHAN JK. The new World Health Organization classification of lymphoma.The past,the present and the future[J]. Hematol Duco,2001,19(1) : 129-150. 被引量：1
6SHIPP MA, HARRINGTON DP, ANDERSON JR, et al. A predictive model for aggressive non-Hodgkin's lymphoma. The international non-Hodgkin's lymphoma prognostic factors project[J]. N Engl J Med, 1993,329(14) :987-994. 被引量：1
8ALVARNAS JC, FORMAN SJ. Graft purging in autologous bone marrow transplantation: a promise not quite fulfilled [J]. Oncology ,2004,18(7) :867-876. 被引量：1
9HOERR AL,GAO F,HIDALGO J, et al. Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma [J]. J Clin Oncol, 2004,22 (22) : 4561-4566. 被引量：1
10Bueno J, Ramil C, Somoza I, et al. Treatment of monomorphio B-cell lymphoma with rituximab after liver transplantation in a child [J].Pediatr Transplant, 2003, 7 ( 2 ): 153-156. 被引量：1
